FDA panel recommends approval of new facial filler

05/7/2013 | SkinAndAllergyNews.com

An FDA advisory panel recommended approval of Allergan's injectable Juvederm Voluma XC filler to treat age-related loss of midface volume. The product combines high- and low-molecular-weight hyaluronic acid and lidocaine and has a thick consistency intended for subcutaneous and supraperiosteal injection.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health